Strides Pharma Science Ltd received an order from the Reserve Bank of India to pay Rs. 1.51 Crores for non-compliance related to ESOPs granted to a non-resident employee, stemming from R&D spending requirements that were not met in previous years. The company acknowledged the order and states it will not materially impact its finances or operations.